The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
ABT-414 in patients with advanced solid tumors likely to overexpress the epidermal growth factor receptor (EGFR).
 
Glenwood D. Goss
No Relationships to Disclose
 
Everett E. Vokes
Consulting or Advisory Role - Abbvie; AstraZeneca; Boehringer Ingelheim; Celgene; Clovis Oncology; Eisai; GeneCentric; Genentech; Lilly; Merck; Synta; Transgene; VentiRx
 
Michael S. Gordon
Employment - Pinnacle Oncology Hematology
Research Funding - Abbvie
 
Leena Gandhi
Honoraria - Merck
Consulting or Advisory Role - Genentech/Roche; Merck
Travel, Accommodations, Expenses - Genentech/Roche; Merck
 
Kyriakos P. Papadopoulos
Research Funding - Abbvie (Inst); Daiichi Sankyo (Inst); GlaxoSmithKline (Inst); MedImmune (Inst); Novartis (Inst); Onyx (Inst); Sanofi (Inst)
 
Drew Warren Rasco
Research Funding - Celgene; Daiichi Sankyo; Five Prime Therapeutics; Millennium; Rexahn Pharmaceuticals; Santa Maria Biotherapeutics; Teva
 
Michelle Pedersen
Employment - AbbVie
Stock and Other Ownership Interests - Abbvie
Travel, Accommodations, Expenses - Abbvie
 
Judee S. Fischer
Employment - Abbvie; Abbvie (I)
Stock and Other Ownership Interests - Abbott Diagnostics; Abbott Diagnostics (I); Abbvie; Abbvie (I)
 
Katharine Chu
Employment - Abbvie
Stock and Other Ownership Interests - Abbvie
Research Funding - Abbvie
 
William Ames
Employment - Abbott Diagnostics; Abbvie
 
Hao Xiong
Employment - Abbvie
Stock and Other Ownership Interests - Abbvie
 
Ho-Jin Lee
Employment - Abbvie
Stock and Other Ownership Interests - Acadia Pharmaceuticals (I); Regeneron (I); Sarepta Therapeutics (I); Vertex (I)
 
Jiewei Zeng
Employment - Abbvie
Travel, Accommodations, Expenses - Abbvie
 
Lisa Roberts-Rapp
Employment - Abbott Laboratories; Abbott Laboratories (I); Abbvie; Abbvie (I)
Stock and Other Ownership Interests - Abbott Diagnostics; Abbvie
Patents, Royalties, Other Intellectual Property - Abbott Diagnostics
 
Peter Ansell
Employment - Abbvie; Abbvie (I)
Stock and Other Ownership Interests - Abbvie; Abbvie (I)
Honoraria - Abbvie
Patents, Royalties, Other Intellectual Property - Abbvie
Travel, Accommodations, Expenses - Abbvie; Abbvie (I)
 
Ed Reilly
Employment - Abbvie; Abbvie (I)
Stock and Other Ownership Interests - Abbvie; Abbvie (I)
Patents, Royalties, Other Intellectual Property - Abbvie
Travel, Accommodations, Expenses - Abbvie; Abbvie (I)
 
Kyle D. Holen
Employment - Abbvie
Stock and Other Ownership Interests - Abbvie
 
Anthony W. Tolcher
Stock and Other Ownership Interests - Symphony Evolution
Consulting or Advisory Role - AbbVie; Adnexus; Ambit BioSciences; AP Pharma; Aragon Pharmaceuticals; ARIAD; ArQule; Asana Biosciences; Astellas Pharma; Astex Pharmaceuticals; AVID Radiopharmaceuticals; Bayer Schering Pharma; Bind Therapeutics; BioMed Valley Discoveries; Blend Therapeutics; Bristol-Myers Squibb; Celator; Clovis Oncology; Curis; Dicerna; Eisai; Emergent BioSolutions; Heron; Janssen; Johnson & Johnson; Lilly; MedImmune; Merck Sharp & Dohme; Merus; Micromet; Nanobiotix; Nektar; Neumedicines; Novartis (I); Oncogenex; Pfizer; Pharmacyclics; Pierre Fabre; ProNAi; Proximagen; Symphony Evolution; Vaccinex; Valent Technologies; Zyngenia; Zyngenia